Benzoic acid

CAS No. 65-85-0

Benzoic acid( Benzoic acid | Benzoesaeure | Benzenecarboxylic acid | Benzeneformic acid )

Catalog No. M15503 CAS No. 65-85-0

Benzoic acid is a Nitrogen Binding Agent. The mechanism of action of benzoic acid is as an Ammonium Ion Binding Activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    Benzoic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Benzoic acid is a Nitrogen Binding Agent. The mechanism of action of benzoic acid is as an Ammonium Ion Binding Activity.
  • Description
    Benzoic acid is a Nitrogen Binding Agent. The mechanism of action of benzoic acid is as an Ammonium Ion Binding Activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Benzoic acid | Benzoesaeure | Benzenecarboxylic acid | Benzeneformic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    65-85-0
  • Formula Weight
    122.12
  • Molecular Formula
    C7H6O2
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 24 mg/mL (196.52 mM); DMSO: 24 mg/mL (196.52 mM)
  • SMILES
    O=C(O)C1=CC=CC=C1
  • Chemical Name
    Benzoic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. S, et al. J Neurochem. 2002 Oct;83(1):57-66.
molnova catalog
related products
  • HQNO

    HQNO is a natural product isolated from P. aeruginosa,and is a potent inhibitor of electron transport chain(Kd of 64 nM for complex III).

  • pyridostigmine

    Pyridostigmine?is an?acetylcholinesterase inhibitor?that can treat myasthenia gravis by increasing acetylcholine at the postsynaptic motor endplate.

  • GRGDSP acetate(91037...

    GRGDSP, a synthetic linear RGD peptide, is an integrin inhibitor which can be used to modify the surface of cardiovascular implants such as vascular grafts to promote endothelialization.